tiprankstipranks
Insight Molecular Diagnostics (IMDX)
NASDAQ:IMDX
US Market

Insight Molecular Diagnostics (IMDX) Income Statement

430 Followers

Insight Molecular Diagnostics Income Statement

Last quarter (Q4 2025), Insight Molecular Diagnostics's total revenue was $1.14M, a decrease of -23.35% from the same quarter last year. In Q4, Insight Molecular Diagnostics's net income was $-22.95M. See Insight Molecular Diagnostics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Mar 24Mar 23Dec 21
Total Revenue
$ 4.05M$ 1.88M$ 1.50M$ 958.00K$ 2.20M
Gross Profit
$ 190.00K$ 740.00K$ 413.00K$ -18.00K$ 1.42M
Operating Expenses
$ 30.77M$ 61.78M$ 25.55M$ 17.98M$ 55.15M
Depreciation and Amortization
$ 2.20M$ 1.56M$ 1.68M$ 5.22M$ 4.21M
EBITDA
$ -28.38M$ -59.02M$ -23.12M$ -13.31M$ -48.46M
Operating Income
$ -30.58M$ -61.04M$ -25.14M$ -18.00M$ -53.73M
Other Income/Expenses
$ -19.64M$ 378.00K$ 281.00K$ -615.00K$ 854.00K
Pretax Income
$ -50.22M$ -60.66M$ -24.86M$ -18.61M$ -52.87M
Net Income
$ -50.22M$ -60.66M$ -27.78M$ -72.90M$ -64.10M
Per Share Metrics
Basic EPS
$ -1.65$ -4.66$ -3.75$ -20.00$ -14.40
Diluted EPS
$ -1.65$ -4.66$ -3.75$ -20.00$ -14.40
Weighted Average Shares Outstanding
30.48M 13.07M 7.65M 5.54M 4.45M
Weighted Average Shares Outstanding (Diluted)
30.48M 13.07M 7.65M 5.54M 4.45M
Currency in USD

Insight Molecular Diagnostics Earnings and Revenue History